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We studied the inflammatory reaction related to cardiopulmonary b pass 
in 24 neonates (median age 6 days) undergoing the arterial switch 
operation for simple transposition of the great arteries, with respect o the 
development of postoperative capillary leak syndrome. Complement pro- 
teins, leukocyte count, tumor necrosis factor-a, and histamine levels were 
determined before, during, and after cardiopulmonary bypass. Addition- 
ally, protein movement from the intravascular into the extravascular space 
during cardiopulmonary bypass was assessed by the measurement of 
plasma concentrations of proteins with molecular weights ranging from 
21,200 to 718,000. Capillary leak syndrome developed in 13 of the 24 
neonates. Patients with capillary leak syndrome, as compared with those 
without, had preoperatively higher C5a levels (C5a, 3.0 - 0.6 pg/L vs 0.9 - 
0.2 /.tg/L) (mean ± standard error of the mean) (p < 0.05) and higher 
leukocyte counts (leukocytes, 17.9 _ 2.1 x 103 cells/ml versus 11.7 _ 0.8 x 
103 cells/ml) (p < 0.05), suggesting in these neonates a preoperative 
inflammatory state. Preoperative clinical and operative data were identical 
in both patient groups. Before cardiopulmonary bypass, serum protein 
concentrations were similar in all patients. Ten minutes after institution of
cardiopulmonary bypass, protein concentrations fell to significantly lower 
values in patients with capillary leak syndrome than in those without: 
albumin (19% - 1.5% vs 30% - 6% of the prebypass value, p < 0.05), 
immunoglobulin G (17% - 1.5% vs 29% ± 5.5%, p < 0.001), and 
az-macroglobulin (15% ± 1.2% vs 25% - 4%, p < 0.02). During cardio- 
pulmonary bypass, albumin concentrations remained significantly lower in 
patients with capillary leak syndrome than in those without, whereas 
hematocrit values were similar in both groups. During cardiopulmonary 
bypass, patients with capillary leak syndrome also had lower concentra- 
tions of complement proteins C3 and C4 but not CI  inhibitor. C3d/C3 ratio 
and C5a levels were similar in both patient groups. In contrast, histamine 
liberation during cardiopulmonary bypass was significantly more pro- 
nounced in patients with capillary leak syndrome than in those without 
(725.2 - 396.7 pg/ml vs -54.1 - 58.4 pg/ml, p < 0.05). Tumor necrosis 
factor-a levels after protamine administration were also significantly 
higher in patients with capillary leak syndrome (38.1 ... 10.0 pg/ml vs 
15.3 ... 3.4 pg/ml, p < 0.05). Leukocyte count during and after cardiopul- 
monary bypass was similar in both patient groups. This study demonstrates 
increased protein leakage as early as 10 minutes after initiation of 
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cardiopulmonary bypass in patients having clinical signs of postoperative 
capillary leak syndrome. Patients with capillary leak syndrome displayed 
more pronounced histamine liberation and tumor necrosis factor-a liber- 
ation than patients without capillary leak syndrome, suggesting a relation- 
ship between cardiopulmonary bypass-related inflammatory reaction and 
perioperative capillary damage. A preoperative inflammatory state in 
patients with capillary leak syndrome could have enhanced the inflamma- 
tory response to cardiopulmonary bypass. (J Thorac Cardiovasc Surg 1996; 
112:687-97) 
O Perations involving cardiopulmonary bypass (CPB) induce a complex systemic inflammatory 
reaction including synthesis and systemic release of 
inflammatory mediators. 16 We 7 have previously 
shown that neonates display significant complement 
activation and leukocyte stimulation when undergo- 
ing cardiac operations. 
Among the mediators liberated in the setting of 
CPB, complement anaphylatoxins, vasoactive 
amines such as histamine, and cytokines such as 
tumor necrosis factor-a (TNF-a) have the capability 
to increase microvascular permeability, s' 9 
Increased microvascular permeability and 
changes in water balance hormones and control 
factors of endothelial integrity such as atrial natri- 
uretic peptide 1°' 11 promote interstitial protein-rich 
edema and water accumulation in the interstitial 
space)2, 13 Neonates with normally facilitated fluid 
movements across the capillary membrane, and with 
rapid fluid shift from the intravascular into the 
interstitial space in case of fluid overload, 14 are at 
particularly high risk for the development of gener- 
alized edema as a result of microvascular protein 
leakage during CPB. Indeed, younger age has been 
recognized among risk factors for rise in total body 
water accumulation after cardiac operations. 15De- 
spite the relatively high prevalence of postoperative 
capillary leak syndrome (CLS) in neonates, data on 
the influence of risk factors including CPB-related 
inflammatory reaction are lacking. It was therefore 
the aim of our prospective study to analyze risk 
factors for postoperative CLS and to compare com- 
plement activation, leukocyte counts, TNF-a pro- 
duction, and histamine liberation before, during, 
and after CPB operations in neonates with and 
without postoperative development of CLS. 
Patients and methods 
Clinical 
Patients. After approval by the Human Ethical Com- 
mittee of the Aachen University of Technology and 
informed consent of the parents, 24 consecutive term 
neonates aged 2 to 23 days (median 6days) were included 
in this prospective study. Inclusion criterion was a simple 
transposition of the great arteries uitable for the arterial 
switch operation. All patients received prostaglandin E 1 
infusion before the operation to maintain ductus arterio- 
sus patency. Maternal-fetal infection or bacterial infection 
before the operation, eonatal asphyxia, and preoperative 
organ dysfunction were excluded in all cases. Cardiac 
catheterization for balloon atrial septostomy and angio- 
cardiography was performed in 16 patients 1 to 18 days 
before the operation. Thirteen patients were treated by 
mechanical ventilation for 24 to 264 hours before the 
operation for respiratory insufficiency caused by prosta- 
glandin E 1. 
Anesthesia and antibiotic regimen. Conventional general 
anesthesia was performed. Cefotiam hydrochloride (25 
mg/kg) and dexamethasone (3 mg/m 2body surface area) 
given for prophylaxis of cerebral edema were adminis- 
tered before sternotomy. 
CPB. The CPB protocol included a roller pump, a 
disposable membrane oxygenator, and an arterial filter. 
Cooling and rewarming were carried out with a heat 
exchanger. The priming solution consisted of a crystalloid 
solution, mannitol (3 ml/kg), and packed red cells to 
obtain a hematocrit value of the circulating volume of 
about 25%. Heparinization was achieved with heparin 
sulfate (3 mg/kg). Aprotinin was given intravenously 
(10,000 IU/kg) on induction of CPB and mixed in the 
priming solution (10,000 IU/kg). For vasodilation i  the 
cooling and rewarming periods, all neonates received a
continuous infusion of sodium nitroprusside (0.5 to 2.3 
/xg/kg per minute, median 1 /xg/kg per minute). Blood, 
fresh frozen plasma, and albumin were not substituted 
before the beginning of rewarming at the end of CPB. 
CPB was instituted with a perfusion index of 2.7 
L/min × m z, which was maintained throughout the cool- 
ing phase. After deep hypothermia was reached (minimal 
nasopharyngeal temperature averaging 15°C), aortic 
crossclamping was done, cardioplegia was induced by a 
single intraaortic injection of a 4°C cold Bretschneider 
solution (30 ml/kg), and complete circulatory arrest was 
instituted for not longer than 60 minutes. If necessary, the 
surgical procedure was continued under low-flow perfu- 
sion (25% of the calculated initial perfusion rate). Re- 
warming was achieved under full-flow conditions. The 
lungs of the neonates were reventilated when core tem- 
perature reached 30 ° C. Neutralization of heparin was 
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achieved with protamine sulfate in a 1:1 ratio. Epineph- 
rine, dopamine, and sodium nitroprusside were systemat- 
ically administered for weaning of the patients from CPB. 
Postoperative care. Postoperative monitoring included 
continuous registration of heart rate and rhythm, arterial 
blood pressure, central venous pressure, and urine output. 
Target values for mean arterial blood pressure, central 
venous pressure, and urine output during the first 72 
hours after the operation were about 45 mm Hg, 5 to 7 
mm Hg, and more than 1.5 ml/kg per hour, respectively. 
Inotropic support, vasodilatory treatment, and diuretic 
treatment consisting of epinephrine, dopamine, sodium 
nitroprusside, and furosemide were adapted accordingly, 
as was volume substitution, which was carried out with 
fresh frozen plasma or 5% human albumin. Fluid balance 
(fluid input including crystalloid and colloid solutions, 
fluid output including urine and drainage secretions) was 
assessed every 4 hours for the first 72 hours after the 
operation. Specific cardiologic examinations included 
electrocardiograms and echocardiograms, performed at 
least once a day, which allowed the evaluation of cardiac 
rhythm and function as assessed by the size of cardiac 
cavities and ventricular wall motion. Repeated sonograms 
of the chest and abdomen allowed diagnosis of pleural 
and intraabdominal effusions. Chest roentgenograms were 
carried out at the bedside under constant conditions 
(film-focus distance, I m, patient in the supine position) at 
least once a day during the 3 first postoperative days. 
So that tissue edema could be quantified, a radiologic 
index was established. The radiologic index was calculated 
as the ratio of the dimension of soft tissues measured at 
the height of the eighth rib to the diameter of the eighth 
rib measured at the midclavicular line, the latter serving as 
a reference being unaffected by edema and variations of 
thoracic geometry. Measurements were performed on the 
preoperative chest x-ray film, 1 hour after the operation, 
and on the first, second, and third postoperative days. 
Besides blood gas analysis and serum electrolytes, erum 
creatinine, aspartate aminotransferase, and creatine ki- 
nase were routinely measured uring the first 3 days after 
the operation. The ratio of arterial oxygen tension (milli- 
meters of mercury) to inspired oxygen fraction was used as 
an oxygenation parameter in patients receiving ventilatory 
assistance. 
Definition of postoperative CLS. CLS was defined as the 
development of noncardiogenic generalized edema in- 
cluding pleural effusions or ascites (or both) and blood 
pressure instability necessitating volume substitution. 
Laboratory tests 
Collection of samples. Venous blood was collected be- 
fore and after the operation. During CPB, blood was 
withdrawn from the arterial ine of the circuit. For each 
sample time, 2.0 ml of blood was taken in tubes containing 
ethylenediaminetetraacetic acid. The samples were imme- 
diately centrifuged for 3 minutes (3000 rpm) and the 
plasma was stored at -70 ° C until analysis. 
Plasma samples were collected before the operation, 
after heparin administration, 10 minutes after the onset of 
CPB, after complete circulatory arrest, 10 minutes after 
recirculation, after lung reventilation, at the end of the 
rewarming period, after protamine administration, and 4, 
24, 48, and 72 hours after the end of CPB. 
Complement fractions. C3, C4, and C1 inhibitor (molec- 
ular weight [MW] 190,000, 198,000, and 90,000, respec- 
tively) were determined by laser nephelometry 16 with the 
immunoglobulin G fraction of a rabbit antihuman C3, C4, 
or C1 inhibitor antiserum with an automated procedure 
(Behring nephelometer analyzer, Behring Diagnostics, 
Hoechst, Belgium). 
For C3d (MW 35,000) determination, the sample was 
incubated (volume/volume) with borate buffer contain- 
ing 22% polyethylene glycol for one night at 4 ° C. After 
centrifugation to discard the C3 molecules, the super- 
natant was analyzed by laser nephelometry asdescribed 
for C3 with the following modifications: the sample 
diluent was supplemented with 20% distilled water to 
allow a reduction of polyethylene glycol to a maximum 
of 3.5% in the reaction mixture during immunoprecipi- 
ration. 
C3d/C3 ratio was used as index of C3 conversion. C5a 
(MW 11,000) was determined by enzyme immunoassay 
Enzygnost C5a, Behring (Hoechst, Brussels, Belgium). 
Normal range for healthy adults is 0.15 to 0.45 /xg/L. 
TNF-a. TNF-a (MW 20,000) was determined by 
means of an immunoenzymetric assay (enzyme ampli- 
fied sensitivity immunoassay, Medgenix Diagnostics SA, 
Fleurus, Belgium) according to the manufacturer's rec- 
ommendations. It is a solid-phase enzyme-amplified 
sensitivity immunoassay performed on a microtiter 
plate, based on the oligoclonal system, in which several 
monoclonal antibodies directed against distinct 
epitopes of the intact cytokine are used, thus allowing 
high sensitivity. The minimal detectable concentration 
is 3 pg/ml. Normal TNF-a values in healthy adults are 
lower than 20 pg/ml. 
Histamine. Histamine (MW 110) was determined by 
immunoenzymatic dosage (Immunotech International, 
Marseille, France) based on competition between sample 
histamine and histamine-acetylcholine esterase. The spec- 
ificity was increased through acylation of sample and 
tracer histamine and by use of monoclonal antibodies 
against acylated histamine. Normal plasma histamine lev- 
els in healthy adults are less than 1000 pg/ml. 
Blood elements. Hematocrit values and leukocyte 
counts were determined by a Coulter counter (Coulter 
Electronics, Inc., Hialea, Fla.). 
Albumin, retinol binding protein, immunoglobuIin G, and 
~2-macroglobulin. Concentrations of albumin (MW 
66,440), retinol binding protein (MW 21,200), immuno- 
globulin G (MW 160,000), and c~2-macroglobulin (MW 
718,000) were determined by laser nephelometry and used 
during CPB as markers of microvascular leakage. 
C-reactive protein. C-reactive protein was determined 
by laser nephelometry. Detection limit of the methods is 5 
mg/L. 
Statistical analysis. Results are expressed by the mean 
value + standard error of the mean. For intergroup 
comparison of clinical and of biologic variables at specific 
sample times, the nonparametric Mann-Whitney U test 
was used. The Spearman rank correlation coefficient was 
assessed for correlation of independent parameters and 
the Fisher exact est for the analysis of contingency tables. 
P values < 0.05 were considered significant. 
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Table I. Clinical characteristics of patients with and 
without CLS 
With CLS Without CLS 
Variables (n = 13) (n = 11) p Value 
Anasarca (n) 13 0 
Pleural effusions (n) 13 0 
Ascites (n) 7 0 
Radiologic index 
Preop. 1.9 -+ 0.2 1.7 _+ 0.1 
1 hr postop, 2.0 -+ 0.2 2.0 _+ 0.1 
24 hr postop. 2.6 -+ 0.4 1.8 _+ 0.1 
48 hr postop. 4.2 _+ 0.8 2.1 _+ 0.3 
NS 
NS 
0.08 
<0.01 
Values as number (n) or mean -+ standard error of the mean. NS, Not 
significant. 
Results 
Clinical results. According to our definition, 
CLS developed in 13 of the 24 investigated patients. 
Clinical characteristics and radiologic index, which 
was significantly higher in patients with CLS on the 
second postoperative day, are shown in Table I. 
In all 24 neonates, echocardiograms and electro- 
cardiograms allowed us to exclude significant post- 
operative cardiac dysfunction and rhythm disorders. 
One patient with CLS had clinical and angiographic 
signs of thrombosis of the right and left superior 
venae cavae on the fourth postoperative day. This 
patient died of this complication 3 months after the 
operation. 
Age at operation, preoperative dosage of prosta- 
glandin El, frequency of cardiac atheterization a d 
atrial septostomy as well as delay between this 
procedure and operation, and frequency of preop- 
erative mechanical ventilation were not significantly 
different in patients with and without CLS. Duration 
of CPB, aortic crossclamp time, complete circula- 
tory arrest, and minimal nasopharyngeal tempera- 
ture and flow rates during CPB were similar in 
patients with and without CLS, as was inotropic and 
vasodilatory support during and immediately after 
CPB. Fluid balance and urine output during CPB 
were not significantly different in patients with and 
without CLS. The volume of fresh frozen plasma but 
not albumin administered at the end of CPB was 
greater in patients with CLS (p = 0.08). Table II 
summarizes preoperative and perioperative patient 
data. 
The volume of fresh frozen plasma and albumin 
administered over the first 3 postoperative days was 
greater in patients with CLS than in those without 
CLS. Infusion of albumin and fresh frozen plasma 
became unnecessary in all patients with or without 
CLS from the fourth postoperative day on. 
Fluid balance over the first 24 hours after the 
operation was significantly more positive in patients 
with CLS than in those without, but urine output 
and serum creatinine concentrations during the first 
postoperative day were similar in both patient 
groups. However, transient renal failure developed 
in two patients with CLS. After the third postoper- 
ative day, all patients had a negative fluid balance 
that averaged -0.30 _+ 0.60 and -0.34 _ 0.30 ml/kg 
per hour in patients with and without CLS, respec- 
tively. 
Arterial blood pressure and inotropic and vasodi- 
latory support during the first postoperative day 
were similar in patients with and without CLS, 
whereas central venous pressure 24 hours after the 
operation was significantly higher in patients with 
CLS than in those without. 
Aspartate aminotransferase and creatine kinase 
levels measured 24, 48, and 72 hours after the 
operation were similar in both patient groups. Oxy- 
genation index during the first postoperative day 
was identical in both groups. Duration of mechani- 
cal ventilation after the operation and duration of 
stay in the intensive care unit was significantly 
longer in patients with CLS. 
Table III summarizes postoperative clinical data 
of patients with and without CLS. 
Laboratory tests 
Hematocrit values and albumin, retinol binding 
protein, immunoglobulin G, and o~:-macroglobulin 
concentrations. The course of hematocrit values be- 
fore, during, and after CPB was similar in patients 
with and without CLS. Hematocrit value fell imme- 
diately after institution of CPB from normal preop- 
erative values for age (40.2% _+ 1.5% and 41.2% ___ 
1.0% [mean _+ standard error of the mean] to 22.7% 
-+ 0.5% and 23.4% _ 0.9%) in patients with and 
without CLS, respectively. Hematocrit reached nor- 
mal values again after the end of CPB (34.1% ___ 
1.7% and 33.8% _+ 1.5% in patients with and 
without CLS, respectively). 
Albumin concentrations were similar in both pa- 
tient groups before CPB and fell in all patients after 
institution of CPB. Albumin concentrations during 
CPB were lower in patients with CLS than in those 
without CLS throughout the duration of CPB (p < 
0.05). After lung reventilation, albumin concentra- 
tion fell in patients without CLS, reaching low 
values similar to those of patients with CLS. Fig. 1 
shows the course of albumin concentrations before, 
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Table II. Preoperative and perioperative data 
With CLS Without CLS 
Variables (n = 13) (n = 11) p Value 
Age at operation (days) 7 (2-23) 6 (3-12) 
Cardiac catheterization ( ) 9 7 
Delay between cardiac catheterization a d operation (days) 6.1 _+ 1.7 5.6 _+ 1.5 
Preoperative mechanical ventilation (n) 9 4 
Duration of preoperative mechanical ventilation (hr) 96 (24-264) 48 (48-96) 
Preoperative PGE1 dosage (p,g/kg/min) 0.038 +_ 0.01 0.036 _+ 0.01 
Duration of CPB (rain) 55.6 _+ 4.1 50.6 _+ 5.4 
Duration of aortic clamping (rain) 66.0 +_ 2.3 64.9 _+ 9.9 
Duration of CCA (rain) 60.2 +_ 1.4 58.1 _+ 1.5 
Minimal nasopharyngeal temperature (°C) 15.1 _+ 0.5 14.3 + 0.5 
Flow rate 10 minutes after initiation of CPB (ml/min • m 2) 2.7 + 0.1 2.7 + 0.05 
Flow rate after recirculation CCA (ml/min • m 2) 1.7 + 0.2 1.9 _+ 0.3 
Flow rate when lungs reventilated (ml/min • m 2) 2.5 _+ 0.1 2.3 _+ 0.3 
SNP dosage during CPB (p,g/kg/min) 2.0 +_ 0.3 1.7 +_ 0.4 
SNP dosage at the end of CPB (/xg/kg/min) 1.1 _+ 0.03 1.03 _+ 0.15 
Epinephrine dosage at the end of CPB (txg/kg/min) 0.25 +_ 0.03 0.25 _+ 0.06 
Fluid balance during CPB (ml) 73.3 ___ 22.0 79.5 _+ 19.7 
Diuresis during CPB (ml/kg/hr) 12.5 _+ 3.0 8.3 _+ 1.9 
FFP transfusion at the end of CPB (ml/kg) 12.1 +_ 1.9 6.0 _+ 2.3 
Albumin infusion at the end of CPB (n) 3 4 
ml/kg 7.7 (7.5-8.8) 8.3 (4.3-9.3) 
NS 
NS 
NS 
NS 
NS 
NS 
NS 
NS 
NS 
NS 
NS 
NS 
NS 
NS 
NS 
NS 
NS 
0.08 
NS 
PGE1, Prostaglandin El; CPB, cardiopulmonary b pass; CCA, complete circulatory arrest; SNP, sodium nitroprusside; FFP, fresh frozen plasma; NS, not 
significant. Values as number (n), mean ± standard error of the mean, or median (range). 
during, and after CPB in patients with and without 
CLS. 
Retinol binding protein, immunoglobulin G, and 
a2-macroglobulin concentrations were similar in 
both patient groups before CPB. In patients with 
CLS, albumin, immunoglobulin G, and a2-macro- 
globulin fell 10 minutes after institution of CPB, as 
compared with prebypass values, to significantly 
lower relative concentrations than in patients with- 
out CLS (p < 0.05). Relative retinol binding protein 
concentrations tended to be lower in patients with 
CLS, but the difference was not significant (p < 0.1). 
Fig. 2 depicts relative plasma protein concentrations 
in patients with and without CLS. 
Complement fractions. C3 was within the normal 
range before CPB in all patients. C3 reached signif- 
icantly lower values at institution of CPB in patients 
with CLS (p < 0.05), and this difference persisted up 
to the end of CPB. After CPB, C3 tended to remain 
lower in patients with CLS, but the difference was 
not significant (Fig. 3). 
The course of C4 was comparable with that of 
C3 (Fig. 4), whereas C1 inhibitor levels in patients 
with and without CLS were not statistically differ- 
ent (Fig. 5). 
Before the operation, C3d/C3 averaged 1.8 +_ 0.3 
in patients with CLS and 1.2 2 0.1 in patients 
without CLS (p = not significant). After protamine 
administration, C3d/C3 rose to 2.8 +_ 0.3 and 2.6 + 
0.4 in patients with and without CLS, respectively 
(p = not significant). C5a was abnormally elevated 
in all patients before the operation; C5a values at 
this time were higher in patients with CLS (C5a, 
3.0 + 0.6/~g/L) than in patients without CLS (C5a, 
0.9 +- 0.2/xg/L) (p < 0.05). However, there was no 
longer a difference between patients with and with- 
out CLS during and after CPB. 
Preoperative C5a values correlated with cumula- 
tive fluid balance over the first 24 postoperative 
hours (Spearman, 0.47, p < 0.05), with radiologic 
index on the first and second postoperative days 
(Spearman, 0.70 and 0.47, respectively, p < 0.05), 
and with duration of mechanical ventilation after 
the operation (Spearman, 0.67, p < 0.05). Preoper- 
ative C5a was not significantly different in patients 
who were or were not treated by mechanical venti- 
lation before the operation. 
TNF-oc TNF-a was similar in both patient groups 
before and during CPB. After protamine adminis- 
tration, patients with CLS had significantly higher 
TNF-a values than patients without CLS (p < 0.05) 
(Fig. 6). TNF-a tended to remain higher in patients 
with CLS 4 hours after the operation, but the 
difference was not significant. TNF-a during and 
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Table III. Postoperative clinical data 
With CLS Without CLS 
Variables (n = 13) (n = 11) p Value 
Mean blood pressure (mm Hg) 
4 hr postop. 61 + 2.8 59 _+ 1.9 NS 
24 hr postop. 52 --+ 1.7 54.5 _+ 1.7 NS 
Central venous pressure (ram Hg) 
4 hr postop. 5.7 + 0.3 4.7 _+ 0.6 NS 
24 hr postop. 7.4 + 0.5 5.4 _+ 0.4 <0.05 
Epinephrine dosage 0zg/kg/min) 
4 h postop. 0.21 + 0.05 0.15 _+ 0.03 NS 
24 hr postop. 0.21 ___ 0.1 0.14 + 0.08 NS 
SNP dosage (txg/kg/min) 
4 hr postop. 1.2 + 0.1 1.03 _+ 0.11 NS 
24 hr postop. 1.2 + 0.08 1.0 _+ 0.15 NS 
Cumulative FFP and HAIb substitution over the 3 first postop, days (ml/kg) 94.2 --- 11.3 65.6 _+ 16.4 0.075 
Fluid intake 24 hr postop. (ml/kg/hour) 4.5 + 0.4 2.5 _+ 0.3 <0.005 
Renal insufficiency (n) 2 0 
Maximal creatinine value 69.1 -+ 11.0 52.9 _+ 2.6 NS 
Paoz/Fio 2 
4 hr postop. 204 + 30 242 _+ 40 NS 
24 hr postop. 203 _+ 31 245 _+ 37 NS 
Duration of mechanical ventilation (hr) 139 -+ 15" 68 _+ 6 <0.005 
Maximal aspartate aminotransferace concentration (IU/L) 61 _+ 24 33 + 3 NS 
Maximal creatinekinase concentration (IU/L) 400 _+ 108 286 _+ 19 NS 
Duration of stay in intensive care unit (days) 9.5 + 1.6" 5 _+ 0.5 <0.005 
Death (n) 1 0 NS 
SNP, Sodium nitroprusside; FFP, fresh frozen plasma; HAlb, human albumin. Values as number (n) or mean _+ standard error of the mean. 
*n = 12 (patient who died excluded). 
after CPB in both groups did not correlate with the 
duration of CPB, aortic crossclamp time, or com- 
plete circulatory arrest. 
Histamine. Histamine release during CPB (hista- 
mine concentration after protamine administra- 
tion - histamine concentration at institution of 
CPB) was significantly higher in patients with CLS 
(724 _+ 396 pg/ml) than in patients without CLS 
( -50 + 58 pg/ml) (p < 0.05). 
Leukocytes and differentiation. Before the opera- 
tion, leukocyte count was significantly higher in 
patients with CLS (17.9 + 2.1 × 103 cells/ml) than in 
those without (11.7 + 0.8 × 103 cells/ml) (p < 0.05). 
During and after CPB, leukocyte counts were simi- 
lar in both patient groups (data not shown). Preop- 
erative leukocyte count correlated with cumulative 
fluid balance over the first 24 postoperative hours 
(Spearman, 0.50, p < 0.05) and with the radiologic 
index calculated on the second postoperative day 
(Spearman, 0.45, p < 0.05). 
C-reactive protein. Eight patients with and seven 
patients without CLS had preoperatively detectable 
C-reactive protein values (p = not significant). 
Among these patients, C-reactive protein averaged 
19.0 _+ 5.0 mg/L in patients with CLS and 6.8 + 0.6 
mg/L in patients without CLS (p = not significant). 
C-reactive protein measured on the first, second, 
and third postoperative days averaged 29.3 + 3.5 
rag/L, 40.5 _+ 6.5 rag/L, and 25.2 + 4.8 rag/L, 
respectively, and was similarly elevated in both 
patient groups. 
Discussion 
Our results demonstrate hat neonates undergo- 
ing the arterial switch operation for transposition of 
the great arteries in whom postoperative CLS de- 
veloped had, in contrast to patients without this 
complication, increased protein leakage from the 
intravascular into the extravascular space as early as 
10 minutes after initiation of CPB. Inasmuch as the 
makeup of the priming solution and perioperative 
course of hematocrit values were strictly similar in 
both patient groups, more pronounced hemodilu- 
tion was excluded as a cause of lower protein 
concentrations in patients with CLS. 
In our series, increased microvascular leakage in 
patients with CLS soon after institution of CPB was 
observed for proteins with MWs ranging from 
21,200 to 718,000, suggesting that gap formation on 
the microvascular basement membrane allowed not 
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Fig. 1. Course of albumin concentrations before, during, 
and after CPB in neonates with (black) and without 
(white) CES. *Significant difference between th  two 
groups (p < 0.05). CCA, Complete circulatory arrest; 
recirc, recirculation; revent, reventilation; rewarm, rewarm- 
ing; prota, protamine. 
only small but also macromolecular proteins uch as 
o~2-macroglobulin to leave the intravascular space, 
as reported for the idiopathic form of CLSJ 7 Albu- 
min concentrations remained lower in patients with 
CLS throughout the procedure until lung reventila- 
tion, when albumin reached similarly low concentra- 
tions in both groups, probably because of the rela- 
tive overadministration f fresh frozen plasma at 
this time in patients with CLS. 
In our series, patients with CLS had no signs of 
severe pulmonary edema s shown by the postoper- 
ative ratios of arterial oxygen tension to inspired 
oxygen concentration measured uring the first 
postoperative day, which were similar to those mea- 
sured in patients without CLS, as also described in 
the idiopathic form of CLS) s Nevertheless, patients 
with CLS needed mechanical ventilation for a 
longer period. This may be ascribed to decreased 
thoracic wall compliance caused by anasarca nd by 
pleural effusions, which were present only in this 
group, according to the definition of CLS. Transient 
renal failure occurred in two of the 13 patients with 
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Fig. 2. Relative concentration (expressed as percentage 
of the prebypass value) of retinol-binding protein (RBP), 
albumin (ALB), immunoglobulin G (IgG), and c~2-macro- 
globulin (cQ-MG) 10 minutes after institution of CPB in 
neonates with (black) and without (white) CLS. *Signifi- 
cant difference between the two groups (p < 0.05). 
CLS and in none without, suggesting impaired renal 
perfusion caused by glomerular capillary damage or 
hypovolemia (or both) in patients with CLS. Indeed, 
over the first postoperative days, patients with CLS 
required higher volume administration but not in- 
creased inotropic support for hemodynamic stabili- 
zation than did patients without CLS. 
Higher central venous pressure on the first post- 
operative day in patients with CLS could be the 
result of increased pulmonary vascular esistance 
and could have in turn maintained fluid shift from 
the intravascular into the extravascular space during 
the postoperative period. 19 Arterial vasodilators 
during and after CPB, which were administered in 
the same dosage in both patient groups, are in our 
series unlikely to have influenced the development 
of CLS, in contrast to experimental results in dogsJ 9 
In one patient with CLS, thrombosis of the right and 
left superior venae cavae developed, which certainly 
contributed tothe persistence ofgeneralized edema 
by impairing lymphatic return. 
CPB induces production and liberation of inflam- 
matory mediators that have the capability to in- 
crease microvascular permeability, e' 5 Among these 
mediators, TNF-o~ (which is mainly produced by 
activated monocytes and macrophages 2°) and hista- 
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Fig. 4. Course of C4 before, during, and after CPB in neonates with (black) and without (white) CLS. 
Abbreviations as in Fig. 1. PO, Postoperatively. *Significant difference between the two groups (p < 0.05). 
mine (which is principally released from activated 
basophils in the setting of CPB 6) are recognized to 
play a major role in increased microvascular perme- 
ability. The exact mechanism underlying microvas- 
cular damage by these mediators is not fully under- 
stood, but it could involve loss of the negative 
charges of the endothelial monolayer of postcapil- 
lary venules, causing endothelial cell contraction 
and gap formation. 8 Increased microvascular per- 
meability caused by cytokines and acute agonists of 
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Fig. 5. Course of C1 inhibitor (Cl-inh) before, during, 
and after CPB in neonates with (black) and without 
(white) CLS. Abbreviations a  in Fig. 1. PO, Postopera- 
tively. 
inflammation occurs either directly or via neutrophil 
activation and oxygen-derived free radical release, s 
By inducing expression of cell surface adhesion 
molecules, TNF-o~ is thought o play an important 
role in leukocyte-endothelium nteractions and in 
oxidant release from adherent neutrophils, causing 
increased microvascular permeability and tissue 
damage. 21Cytokines and acute agonists of inflam- 
mation have recently been demonstrated to act 
synergistically in vitro, 9' 2z this effect allowing the 
reduction of TNF-~ concentrations for the induc- 
tion of similar changes of the endothelial monolayer 
permeability. 
In our series, higher histamine liberation during 
CPB and higher TNF-o~ synthesis n patients with CLS 
suggest hat in neonates undergoing cardiac opera- 
tions, these inflammatory mediators could be respon- 
sible, at least in part, for increased microvascular 
permeability. However, at the time when higher pro- 
tein leakage was already measured in patients with 
CLS (namely, 10 minutes after induction of CPB), 
none of the measured mediators could yet be detected 
in significantly higher concentrations. The reason for 
this discrepancy might be that in patients with CLS 
histamine and TNF-a, together with other plasma 
proteins, left the intravascular space. 
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Fig. 6. Course of TNF-a before, during, and after CPB in 
neonates with (black) and without (white) capillary leak 
syndrome. Abbreviations a in Fig. 1. PO, Postoperatively. 
*Significant difference between the two groups (p < 0.05). 
In contrast o increased histamine liberation and 
TNF-a synthesis n patients with CLS, increased com- 
plement activation during CPB was not demonstrable 
in our series. Indeed, levels of complement proteins 
C3 and C4 during CPB were significantly lower in 
patients with CLS than in those without, mimicking 
the course of proteins of similar size such as immuno- 
globulin G. Thus, because of increased vascular per- 
meability in patients with CLS, consumption and ex- 
travascular leakage of complement proteins cannot be 
differentiated. Furthermore, increased generation of 
complement anaphylatoxins also could have been 
masked, explaining similar C3d/C3 and C5a values 
measured at the end of CPB in both patient groups. 
Inasmuch as leukocyte activation was greater in pa- 
tients with CLS, as shown by higher histamine and 
TNF-a release, and complement anaphylatoxins play 
an important role in early cellular stimulation during 
CPB, 23 a higher degree of complement activation in 
patients with CLS cannot be excluded here. Leukocyte 
counts during and after CPB were similar in both 
patient groups, indicating similar cellular traffic, prob- 
ably caused by similar circulating amounts of chemoat- 
tractant substances such as C5a. 24 
6 9 6 Seghaye t al. 
The Journal of Thoracic and 
Cardiovascular Surgery 
September 1996 
In accordance with reports on idiopathic CLS 
where normal values of both antigenic and func- 
tional C1 inhibitor are described, 25 C1 inhibitor 
levels during and after CPB in our series were not 
significantly different in patients with and without 
CLS. This contrasts, however, with low C1 inhibitor 
levels measured in patients with sepsis-related 
CLS, 26 suggesting that in the setting of CPB, C1 
inhibitor deficiency does not play a dominant phys- 
iopathologic role. 
In our series, patients who had CLS before the 
operation displayed significantly higher C5a levels 
and leukocyte counts than patients who did not have 
CLS. Even though the C-reactive protein concentra- 
tion was not significantly different, this indicates a 
preoperative inflammatory state in patients having 
CLS that was independent ofbacterial infection and 
preoperative management, including prostaglandin 
Ea regimen, cardiac catheterization, and preopera- 
tive mechanical ventilation. This is in accordance 
with our previous report showing abnormal preop- 
erative complement activation in some but not all 
neonates undergoing cardiac operations. 7 The cause 
of this preoperative inflammatory state remains to 
be clarified. In our series it could have enhanced the 
CPB-related inflammatory eaction by cellular prim- 
ing of inflammatory mediators 27 and might be the 
clue for the early increased microvascular injury that 
we observed in neonates in whom CLS developed. 
This contention is supported by the correlation 
observed in our series between preoperative C5a 
levels and leukocyte count and postoperative radio- 
logic index and fluid balance. 
In conclusion, our results how that neonates with 
clinical signs of CLS after cardiac operations have 
higher preoperative circulating levels of comple- 
ment anaphylatoxin C5a and higher leukocyte 
counts, indicating a preoperative inflammatory 
state, than do neonates without this complication. 
Neonates with CLS also have higher CPB-related 
liberation of histamine and TNF-a release (both 
mediators of increased microvascular permeability) 
and show extravascular p otein leakage as early as 
10 minutes after initiation of CPB. A preoperative 
inflammatory state in neonates having CLS could 
enhance the inflammatory response to CPB and 
thereby perioperative capillary damage. 
We thank Isa Sprangers, Henri Collet, and Henri 
Schreyen for technical assistance and Karen Buro for 
statistical advice. 
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